Three-week combination chemotherapy with S-1 and cisplatin as first-line treatment in patients with advanced gastric cancer: a retrospective study with 159 patients

By Koo Dong   Ryu Min-Hee   Ryoo Baek-Yeol   Lee Sung-Sook   Moon Jung-Hwa   Chang Heung-Moon   Lee Jae-Lyun   Kim Tae   Kang Yoon-Koo  

Gastric Cancer, Vol. 15, Iss. 3, 2012-07 ,pp. : 305-312

Springer Publishing Company

Access to resources Recommend Favorite

The efficacy and safety of reduced-dose docetaxel, cisplatin, and 5-fluorouracil in the first-line treatment of advanced stage gastric adenocarcinoma

By Özdemir Nuriye   Abalı Hüseyin   Öksüzoğlu Berna   Budakoglu Burçin   Uncu Doğan   Güler Tunç   Odabaşı Hatice   Zengin Nurullah  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 680-684

Humana Press, Inc

Access to resources Recommend Favorite

A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

By Chao Yee   Hsieh Jan-Sing   Yeh Hsien-Tang   Su Yu-Chieh   Wu Cheng-Chung   Chen Jen-Shi   Tai Cheng-Jeng   Bai Li-Yuan   Yeh Kun-Huei   Su Wu-Chou   Li Chung-Pin  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 4, 2014-04 ,pp. : 799-806

Springer Publishing Company

Access to resources Recommend Favorite

Comparative analysis of the efficacy and safety of modified FOLFOX-6 and DCF regimens as first-line treatment in advanced gastric cancer

By                

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1160-1164

Science Publishers

Access to resources Recommend Favorite

Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer

By Barone Carlo   Basso Michele   Schinzari Giovanni   Pozzo Carmelo   Trigila Nunziatina   D'Argento Ettore   Quirino Michela   Astone Antonio   Cassano Alessandra  

Gastric Cancer, Vol. 10, Iss. 2, 2007-06 ,pp. : 104-111

Springer Publishing Company

Access to resources Recommend Favorite